Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Sept 2018 for Fusion Antibodies plc, €2,366.
Filing timeline
BuySaleRichard John Buick
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -4.3%Entry £0.71 · Close at T+365 £0.68
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Richard John Buick: trading record in brief
One trade, one date: on 25 September 2018, Richard John Buick disclosed an open-market purchase of €2,366 in Fusion Antibodies plc. No broader history exists yet. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Richard John Buick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 3,000 shares@ £0.7042100.0% of flowLondon Stock Exchange, XLONISIN GB00BDQZGK16FCA-NSM:LSE20180925142357_13804051_20200330111446177_4543-1Canonical exit: 24 Dec 2018 (T+90)
1 of 1 declaration